trending Market Intelligence /marketintelligence/en/news-insights/trending/1AVBR4f5RsFiOF0wr6N-Ug2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Arix Bioscience leads $30M financing for Atox Bio

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Arix Bioscience leads $30M financing for Atox Bio

Arix Bioscience plc led an oversubscribed $30 million series F financing round for Atox Bio.

Participants included new investors Adams Street Partners, Asahi Kasei Corp. and additional undisclosed investors, plus existing investors SR One, OrbiMed, Lundbeckfonden Ventures, Becker and Integra Holdings.

Arix Bioscience is investing $8 million for an equity stake in Atox Bio.

As part of the financing, Arix Bioscience's Jonathan Tobin will be appointed a director of Atox Bio.